Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRTC iRhythm Technologies	$137.70 +0.5%	$106.30	$55.92 ▼ $140.73	$4.40B	1.34	468,037 shs	493,149 shs
PRCT PROCEPT BioRobotics	$53.12 -3.1%	$55.66	$47.04 ▼ $103.81	$2.94B	1.1	802,674 shs	470,506 shs
RXST RxSight	$13.13 -0.8%	$19.55	$13.03 ▼ $64.50	$533.34M	1.32	660,937 shs	883,154 shs
SLNO Soleno Therapeutics	$76.77 +0.7%	$62.61	$36.93 ▼ $80.99	$3.83B	-2.67	737,387 shs	950,943 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRTC iRhythm Technologies	+0.55%	+26.20%	+41.51%	+24.58%	+38.76%
PRCT PROCEPT BioRobotics	+3.19%	+3.70%	+12.26%	-21.21%	-9.20%
RXST RxSight	-11.36%	-11.68%	-11.74%	-59.96%	-78.19%
SLNO Soleno Therapeutics	+2.37%	+1.88%	+29.45%	+51.74%	+65.22%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IRTC iRhythm Technologies	1.0639 of 5 stars	2.5	1.0	0.0	3.3	0.0	0.6
PRCT PROCEPT BioRobotics	2.8816 of 5 stars	3.4	2.0	0.0	3.3	3.3	0.6
RXST RxSight	2.777 of 5 stars	4.1	1.0	0.0	2.8	2.5	0.6
SLNO Soleno Therapeutics	4.6091 of 5 stars	4.6	1.0	4.6	2.9	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRTC iRhythm Technologies	2.91	Moderate Buy	$128.55	-6.65% Downside
PRCT PROCEPT BioRobotics	2.86	Moderate Buy	$90.00	69.43% Upside
RXST RxSight	2.20	Hold	$37.60	186.37% Upside
SLNO Soleno Therapeutics	3.20	Buy	$106.78	39.09% Upside

Current Analyst Ratings Breakdown

Latest RXST, IRTC, SLNO, and PRCT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/8/2025	SLNO Soleno Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$81.00 ➝ $97.00
5/8/2025	SLNO Soleno Therapeutics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$102.00 ➝ $105.00
5/2/2025	IRTC iRhythm Technologies	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$152.00 ➝ $139.00
5/2/2025	IRTC iRhythm Technologies	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$133.00 ➝ $150.00
5/2/2025	IRTC iRhythm Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$104.00 ➝ $130.00
5/2/2025	IRTC iRhythm Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$138.00 ➝ $151.00
4/25/2025	PRCT PROCEPT BioRobotics	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$104.00 ➝ $84.00
4/24/2025	SLNO Soleno Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$93.00 ➝ $145.00
4/15/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$18.00
4/15/2025	SLNO Soleno Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$100.00 ➝ $100.00
4/11/2025	PRCT PROCEPT BioRobotics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$90.00 ➝ $70.00

(Data available from 5/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRTC iRhythm Technologies	$618.59M	7.11	N/A	N/A	$6.85 per share	20.10
PRCT PROCEPT BioRobotics	$249.12M	11.80	N/A	N/A	$5.56 per share	9.55
RXST RxSight	$139.93M	3.81	N/A	N/A	$4.47 per share	2.94
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	$5.16 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRTC iRhythm Technologies	-$123.41M	-$3.14	N/A	N/A	N/A	-19.14%	-118.83%	-11.34%	N/A
PRCT PROCEPT BioRobotics	-$105.90M	-$1.70	N/A	N/A	N/A	-50.07%	-38.57%	-26.06%	N/A
RXST RxSight	-$48.61M	-$0.72	N/A	N/A	N/A	-23.92%	-14.00%	-12.51%	N/A
SLNO Soleno Therapeutics	-$38.99M	-$4.26	N/A	N/A	N/A	N/A	-61.99%	-55.21%	N/A

Latest RXST, IRTC, SLNO, and PRCT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2025	Q1 2025	RXST RxSight	-$0.03	-$0.03	N/A	-$0.20	$38.74 million	$37.90 million
5/7/2025	Q1 2025	SLNO Soleno Therapeutics	-$1.14	-$0.95	+$0.19	-$0.95	N/A	N/A
5/1/2025	Q1 2025	IRTC iRhythm Technologies	-$0.89	-$0.95	-$0.06	-$0.97	$153.39 million	$158.68 million
4/24/2025	Q1 2025	PRCT PROCEPT BioRobotics	-$0.49	-$0.45	+$0.04	-$0.45	$65.39 million	$69.16 million
3/5/2025	Q4 2024	SLNO Soleno Therapeutics	-$0.86	-$1.27	-$0.41	-$1.27	N/A	N/A
2/25/2025	Q4 2024	PRCT PROCEPT BioRobotics	-$0.34	-$0.35	-$0.01	-$0.35	$66.79 million	$68.24 million
2/25/2025	Q4 2024	RXST RxSight	$0.10	-$0.15	-$0.25	-$0.15	$40.23 million	$40.21 million
2/20/2025	Q4 2024	IRTC iRhythm Technologies	-$0.29	$0.01	+$0.30	-$0.04	$158.30 million	$164.33 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRTC iRhythm Technologies	9.00	6.27	6.12
PRCT PROCEPT BioRobotics	0.21	6.02	5.07
RXST RxSight	N/A	12.67	11.71
SLNO Soleno Therapeutics	N/A	17.26	17.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRTC iRhythm Technologies	N/A
PRCT PROCEPT BioRobotics	89.46%
RXST RxSight	78.78%
SLNO Soleno Therapeutics	97.42%

Insider Ownership

Company	Insider Ownership
IRTC iRhythm Technologies	1.10%
PRCT PROCEPT BioRobotics	17.40%
RXST RxSight	9.36%
SLNO Soleno Therapeutics	12.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRTC iRhythm Technologies	1,790	31.93 million	31.09 million	Optionable
PRCT PROCEPT BioRobotics	430	55.32 million	43.10 million	Optionable
RXST RxSight	220	40.62 million	36.53 million	Optionable
SLNO Soleno Therapeutics	30	49.91 million	37.81 million	Optionable

RXST, IRTC, SLNO, and PRCT Headlines

Recent News About These Companies

Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025

May 9 at 2:25 AM | uk.finance.yahoo.com

Soleno Therapeutics Inc (SLNO) Q1 2025 Earnings Call Highlights: Navigating Early Success and ...

May 8 at 4:54 AM | finance.yahoo.com

Soleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week High - What's Next?

May 8 at 4:28 AM | marketbeat.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Lifted by Tower Research Capital LLC TRC

May 8 at 3:44 AM | marketbeat.com

Soleno Therapeutics, Inc. (SLNO) Q1 2025 Earnings Call Transcript

May 7 at 11:31 PM | seekingalpha.com

Soleno Therapeutics shares rise on VYKAT XR launch update

May 7 at 6:52 PM | in.investing.com

Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial Results

May 7 at 4:01 PM | globenewswire.com

Alyeska Investment Group L.P. Sells 552,024 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 7 at 5:22 AM | marketbeat.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Comerica Bank

May 7 at 4:53 AM | marketbeat.com

Soleno Therapeutics (SLNO) is on the Move, Here's Why the Trend Could be Sustainable

May 6 at 9:50 AM | zacks.com

Invesco Ltd. Lowers Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 6 at 3:17 AM | marketbeat.com

Mariner LLC Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 5, 2025 | marketbeat.com

Wells Fargo & Company MN Acquires 3,610 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 5, 2025 | marketbeat.com

Ally Bridge Group NY LLC Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 4, 2025 | marketbeat.com

Soleno Therapeutics (SLNO) Projected to Post Earnings on Wednesday

May 2, 2025 | marketbeat.com

Aquatic Capital Management LLC Invests $1.31 Million in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 2, 2025 | marketbeat.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Emerald Mutual Fund Advisers Trust

May 1, 2025 | marketbeat.com

Price T Rowe Associates Inc. MD Grows Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 1, 2025 | marketbeat.com

Comparing Soleno Therapeutics (NASDAQ:SLNO) and Guided Therapeutics (OTCMKTS:GTHP)

May 1, 2025 | americanbankingnews.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Position Lifted by Nantahala Capital Management LLC

April 30, 2025 | marketbeat.com

Artia Global Partners LP Increases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

April 29, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RXST, IRTC, SLNO, and PRCT Company Descriptions

iRhythm Technologies NASDAQ:IRTC

$137.70 +0.70 (+0.51%)

As of 04:00 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

PROCEPT BioRobotics NASDAQ:PRCT

$53.12 -1.69 (-3.08%)

As of 04:00 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

RxSight NASDAQ:RXST

$13.13 -0.10 (-0.76%)

As of 03:52 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Soleno Therapeutics NASDAQ:SLNO

$76.77 +0.51 (+0.67%)

As of 03:58 PM Eastern

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time